Skip to main content
Livermore
Livermore
ZHEN

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595097

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of CRBP: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders34182+49
Shares749.7K168.53M+7.78M (+1,037.8%)
Value$4.53M$97$334.7M+$330.2M (+7,291.4%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (52)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to CRBP in Q1 2024
InstitutionSharesValue% of portfolio
Cormorant Asset Management, LP2,025,000$79.5M3.50%
Point72 Asset Management, L.P.701,597$27.5M0.08%
Adage Capital Partners GP, L.L.C.415,000$16.3M0.03%
Octagon Capital Advisors LP405,000$15.9M1.93%
Citadel Advisors LLC369,167$14.5M0.01%
Janus Henderson Group PLC339,074$13.4M0.01%
Millennium Management LLC324,902$12.7M0.01%
Assenagon Asset Management S.A.259,456$10.2M0.03%
Price T Rowe Associates Inc192,495$7.55M0.00%
Barclays PLC185,148$7.27M0.00%
Walleye Capital LLC132,584$5.20M0.06%
Schonfeld Strategic Advisors LLC124,273$4.88M0.04%
Goldman Sachs Group Inc106,378$4.17M0.00%
Altitude Crest Partners Inc.103,703$4.07M1.74%
Prosight Management, LP100,617$3.95M1.10%
Eversept Partners, LP88,934$3.49M0.26%
Exome Asset Management LLC87,846$3.45M2.95%
Ensign Peak Advisors, Inc67,500$2.65M0.00%
Schroder Investment Management Group64,503$2.53M0.00%
Driehaus Capital Management LLC63,059$2.47M0.02%
Ghost Tree Capital, LLC56,941$2.23M0.72%
Hudson Bay Capital Management LP43,000$1.69M0.01%
Woodline Partners LP40,981$1.61M0.01%
HealthInvest Partners AB38,000$1.49M0.91%
Sphera Funds Management Ltd.35,000$1.37M0.22%
Jane Street Group, LLC32,400$1.27M0.00%
Silverarc Capital Management, LLC31,980$1.25M0.35%
Mirae Asset Global Investments Co., Ltd.24,880$976.3K0.00%
TD Asset Management Inc21,200$831.9K0.00%
Northern Trust Corp20,011$785.2K0.00%
Prelude Capital Management, LLC17,946$704.2K0.05%
Man Group plc17,673$693.5K0.00%
ADAR1 Capital Management, LLC16,000$627.8K0.17%
Squarepoint Ops LLC15,304$600.5K0.00%
Lighthouse Investment Partners, LLC14,943$586.4K0.03%
HRT Financial LP12,314$483.0K0.00%
Trexquant Investment LP11,984$470.3K0.01%
Jefferies Financial Group Inc.11,100$435.6K0.01%
Manufacturers Life Insurance Company, The10,527$413.1K0.00%
XTX Topco Ltd10,290$403.8K0.05%
Renaissance Technologies LLC10,123$397.0K0.00%
Qube Research & Technologies Ltd9,652$378.7K0.00%
Cambridge Investment Research Advisors, Inc.9,182$360.0K0.00%
UBS Oconnor LLC7,500$294.3K0.01%
Standard Life Aberdeen plc5,143$201.8K0.00%
Simplex Trading, LLC1,990$78.0K0.00%
Cutler Group LP800$31.0K0.02%
Quarry LP700$27.5K0.01%
NBC Securities, Inc.33$1.00K0.00%
CoreCap Advisors, LLC25$9810.00%
CIBC Private Wealth Group, LLC1$380.00%
Macquarie Group Ltd507$200.00%

Sold out (3)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of CRBP in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Sio Capital Management, LLC150,000$906.0K
Annapolis Financial Services, LLC23$139
Keener Financial Planning LLC6$0

Not filed for Q1 2024 yet (1)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRBP in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Baystate Wealth Management LLC16$97